08:53 AM EST, 01/22/2026 (MT Newswires) -- Procter & Gamble's ( PG ) fiscal second-quarter revenue fell short of market estimates, although earnings unexpectedly remained steady year over year, while the consumer goods giant reiterated its full-year outlook.
The company on Thursday posted adjusted earnings of $1.88 a share for the quarter ended December, unchanged from the year before, defying the FactSet-polled consensus for a decline to $1.86. Sales ticked up 1% to $22.21 billion, below the Street's view for $22.3 billion.
The stock decreased 0.7% in the most recent premarket activity.
"Our results in the second quarter keep us on track to deliver within our fiscal year guidance ranges for organic sales growth, core EPS growth and adjusted free cash flow productivity in a challenging consumer and geopolitical environment," Chief Executive Shailesh Jejurikar said in a statement. "We have confidence in our plans to deliver stronger results in the second-half of the fiscal year."
The maker of Crest toothpaste and Pampers diapers continues to project adjusted EPS to be in a range of $6.83 to $7.09 for fiscal 2026, while the Street is looking for $6.96. It also maintained its full-year sales growth guidance of 1% to 5% and organic revenue forecast of in line to up 4% year over year.
On a net basis, earnings are now expected to grow between 1% and 6% for the ongoing fiscal year, compared with the company's prior forecast for a 3% to 9% gain, reflecting higher non-core restructuring charges in the year.
Procter & Gamble ( PG ) recorded overall gains of 1% in price in the second quarter, while volume was down by the same percentage. Foreign exchange was a tailwind of 1% to the topline. On an organic basis, which excludes foreign-exchange impact, sales were flat for the quarter while volume decreased 1%.
Sales in the beauty and healthcare segments inclined 5% each to $4.04 billion and $3.41 billion, respectively. Revenue in the fabric and home care division nudged 1% higher to $7.69 billion, while baby, feminine and family care fell 3% to $5.12 billion. Sales in the grooming business increased 2% to $1.79 billion.
Core gross margin declined by 50 basis points on a yearly basis, amid unfavorable mix, product reinvestments and higher costs from tariffs.